We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
On Holding
ONON
$9.73B
| $67.7M | 0.13% |
1,301,100
-94,063
| -7% | -$4.79M |
|
202
Grab
GRAB
$14.6B
| $67.6M | 0.13% |
13,444,746
+1,095,855
| +9% | +$5.11M |
|
203
American Express
AXP
$225B
| $67.2M | 0.13% |
210,564
-21,351
| -9% | -$6.01M |
|
204
Silicon Laboratories
SLAB
$7.3B
| $66.8M | 0.13% |
453,027
-97,665
| -18% | -$11.6M |
|
205
EOG Resources
EOG
$75.5B
| $66.2M | 0.12% |
553,817
-22,706
| -4% | -$2.59M |
|
206
Coupang
CPNG
$29.2B
| $66.2M | 0.12% |
2,210,621
+1,310,337
| +146% | +$33.6M |
|
207
Sherwin-Williams
SHW
$84.3B
| $66M | 0.12% |
192,206
-8,800
| -4% | -$3.05M |
|
208
M&T Bank
MTB
$34.5B
| $65.5M | 0.12% |
337,762
-55,462
| -14% | -$9.79M |
|
209
Birkenstock
BIRK
$5.88B
| $65.5M | 0.12% |
1,331,927
+379,759
| +40% | +$19.5M |
|
210
BWX Technologies
BWXT
$14.3B
| $65M | 0.12% |
450,907
+372,800
| +477% | +$43.6M |
|
211
nVent Electric
NVT
$25.2B
| $64.9M | 0.12% |
885,918
-237,783
| -21% | -$14.6M |
|
212
Clean Harbors
CLH
$16.5B
| $64.6M | 0.12% |
279,341
-122,131
| -30% | -$26.7M |
|
213
Target
TGT
$75.4B
| $64.3M | 0.12% |
651,689
-4,758
| -0.7% | -$457K |
|
214
Ryman Hospitality Properties
RHP
$8.94B
| $64.2M | 0.12% |
650,577
-369
| -0.1% | -$34.5K |
|
215
Ares Management
ARES
$32.4B
| $64.1M | 0.12% |
370,000
-105,000
| -22% | -$16.6M |
|
216
Blackrock
BLK
$183B
| $63M | 0.12% |
60,035
-5,824
| -9% | -$5.51M |
|
217
Rezolute
RZLT
$484M
| $62.6M | 0.12% |
14,034,712
+2,755,385
| +24% | +$10.2M |
|
218
Zoetis
ZTS
$31.2B
| $62.3M | 0.12% |
399,172
-68,430
| -15% | -$10.9M |
|
219
Datadog
DDOG
$86.6B
| $62.2M | 0.12% |
462,771
-580,854
| -56% | -$64.3M |
|
220
Northern Trust
NTRS
$34.1B
| $62.1M | 0.12% |
489,989
+10,243
| +2% | +$1.05M |
|
221
Stryker
SYK
$125B
| $62M | 0.12% |
156,675
+2,242
| +1% | +$839K |
|
222
Arcturus Therapeutics
ARCT
$467M
| $61.1M | 0.12% |
4,694,060
| – | – |
|
223
CAVA Group
CAVA
$7.81B
| $61.1M | 0.11% |
724,855
-499,584
| -41% | -$42.6M |
|
224
Berkshire Hathaway Class B
BRK.B
$1.08T
| $60.6M | 0.11% |
124,767
+315
| +0.3% | +$160K |
|
225
BILL Holdings
BILL
$4.85B
| $60.3M | 0.11% |
1,303,473
+639,502
| +96% | +$28.3M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.